FDA Adverse Event Other Summary report: N

UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM

MDR report key: 1200167 · Received October 1, 2008

Report

Report Number
2122870-2008-00309
Event Type
Other
Date Received
October 1, 2008
Date of Event
September 9, 2008
Report Date
October 1, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
MMI
PMA / PMN Number
K023764
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
NO INFORMATION

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE IN QUESTION WAS LITHIUM HEPARIN PLASMA AND DID NOT VISUALLY APPEAR HEMOLYZED, LIPEMIC OR ICTERIC. THE SAMPLE WAS PROCESSED VIA THE AUTOMATION LINE. QC WAS IN RANGE PRIOR TO AND FOLLOWING THE EVENT. A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED AND ON SITE IN 2008: FSE CONFIRMED ISSUE WAS ISOLATED TO THE ONE PATIENT'S SAMPLE. FSE OBSERVED NO ISSUES VISUALLY WITH THE SYSTEM. FSE PERFORMED A SYSTEM CHECK AND A PRECISION RUN. ALL TEST RESULTS WERE ACCEPTABLE. FSE VERIFIED REPAIR PER ESTABLISHED PROCEDURES AND RESULTS MET PUBLISHED PERFORMANCE SPECIFICATIONS. A CLEAR ROOT CAUSE FOR THIS EVENT HAS NOT BEEN DETERMINED TO DATE, A MALFUNCTION WILL BE ASSUMED FOR THE PURPOSE OF THIS REPORT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) REGARDING AN ERRONEOUSLY ELEVATED ACCU TNI RESULT GENERATED BY THE UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM FOR ONE PATIENT. A PATIENT SAMPLE, WHEN TESTED FOR ACCU TNI, GAVE A RESULT OF 3.84NG/ML. UPON REPEAT, IT GAVE RESULTS OF 0.18 AND 0.09NG/ML. THE ERRONEOUS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE CUSTOMER INDICATED AN ECHOCARDIOGRAM WAS ORDERED AS A RESULT OF THE ERRONEOUSLY ELEVATED RESULTS. HOWEVER, REPORT OF ACTUAL CHANGE TO TREATMENT, DEATH, OR INJURY WAS NOT REPORTED IN CONJUNCTION WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER MMI BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 NA